SG46649A1 - Compositions - Google Patents

Compositions

Info

Publication number
SG46649A1
SG46649A1 SG1996007136A SG1996007136A SG46649A1 SG 46649 A1 SG46649 A1 SG 46649A1 SG 1996007136 A SG1996007136 A SG 1996007136A SG 1996007136 A SG1996007136 A SG 1996007136A SG 46649 A1 SG46649 A1 SG 46649A1
Authority
SG
Singapore
Prior art keywords
pct
sec
date
date dec
pub
Prior art date
Application number
SG1996007136A
Other languages
English (en)
Inventor
Isabelle Richard
Isabelle Thielemans
Nadine Merlet
Original Assignee
Laboratoiresglaxo Wellcome Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoiresglaxo Wellcome Sa filed Critical Laboratoiresglaxo Wellcome Sa
Publication of SG46649A1 publication Critical patent/SG46649A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG1996007136A 1992-05-07 1993-05-05 Compositions SG46649A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
SG46649A1 true SG46649A1 (en) 1998-02-20

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007136A SG46649A1 (en) 1992-05-07 1993-05-05 Compositions

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ID27825A (id) * 1998-03-26 2001-04-26 Fujisawa Pharmaceutical Co Sediaan lepas lambat
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CA2813648C (en) 2010-10-15 2019-06-25 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
CA2870123C (en) 2012-04-18 2021-02-23 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
US5399574A (en) * 1990-06-07 1995-03-21 Burroughs Wellcome Co. Indolyl tetrahydropyridines for treating migraine

Also Published As

Publication number Publication date
RU2118527C1 (ru) 1998-09-10
OA10109A (en) 1996-12-18
GB9209882D0 (en) 1992-06-24
CH685920A5 (fr) 1995-11-15
HK95697A (en) 1997-08-08
CY2039B1 (en) 1998-04-30
NO944214L (no) 1994-11-07
IE75203B1 (en) 1997-08-27
IL105468A (en) 1998-09-24
TW231970B (enExample) 1994-10-11
DE69317418T2 (de) 1998-07-30
GB2266665A (en) 1993-11-10
DE69317418D1 (de) 1998-04-16
HU211638A9 (en) 1995-12-28
BR1100108A (pt) 1999-12-07
WO1993021916A1 (en) 1993-11-11
KR100253111B1 (en) 2000-07-01
ZA933178B (en) 1994-01-10
RO112993B1 (ro) 1998-03-30
BE1007024A5 (fr) 1995-02-21
IE930339A1 (en) 1993-11-17
NZ252132A (en) 1996-09-25
IT1261471B (it) 1996-05-23
GR3026584T3 (en) 1998-07-31
EP0639072B1 (en) 1998-03-11
NO944214D0 (no) 1994-11-04
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
CA2135179A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
FR2690847B1 (fr) 1995-06-09
CA2135179C (en) 2000-12-05
BG99167A (bg) 1995-06-30
CZ283512B6 (cs) 1998-04-15
AU670083B2 (en) 1996-07-04
NO306700B1 (no) 1999-12-13
BG62120B1 (bg) 1999-03-31
US5705506A (en) 1998-01-06
HU227338B1 (en) 2011-04-28
EP0639072A1 (en) 1995-02-22
GB2266665B (en) 1996-05-22
ITRM930286A1 (it) 1994-11-06
UA37206C2 (uk) 2001-05-15
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
HUT71418A (en) 1995-11-28
ES2113533T3 (es) 1998-05-01
AU4064093A (en) 1993-11-29
CZ272394A3 (en) 1995-10-18
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
MX9702865A (es) Agentes estrogenicos.
BG105564A (en) Galantamine-containing composition with controlled release
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
EP0903349A3 (en) CCR-3 receptor antagonists
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PL347671A1 (en) Compounds and compositions for delivering active agents
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BG105534A (en) 5ht1 means and method for the treatment of migraine
GB9209882D0 (en) Compositions
IL114598A0 (en) Triazole compounds their preparation and pharmaceutical compositions containing them
IL114600A (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
EP0485431A4 (en) Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents
GR3036195T3 (en) Novel compounds
AU3524795A (en) Aromatic ethers derived from indols such as 5ht1-like ligands
BG102229A (en) Endothelium receptor antagonists
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
GR3026346T3 (en) Pharmaceutical compositions comprising contignasterol compounds.
IL150082A (en) Unsaturated 14,15 - cyclopropane